Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
about
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives.Epigenetics and allergy: from basic mechanisms to clinical applications.Subclinical lower airways correlates of chronic allergic and non-allergic rhinitis.Asthma Endotypes and an Overview of Targeted Therapy for Asthma.Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation.Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs.New approaches for identifying and testing potential new anti-asthma agents.Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function.Update on new biologics for intractable eosinophilic asthma: impact of reslizumab.Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma.Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma.Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007-2012.
P2860
Q38610303-416685C3-EB08-40C4-917C-8A3EEA00380CQ38613170-180E7EA9-26DF-4A42-9405-C50067E73AD1Q38742430-AD3D2426-6C9E-4519-8718-7AF07F256341Q39250085-C1A8B51F-F545-4F15-A291-89D9034DEE67Q42146218-87519991-F432-413A-AA39-8977514163D2Q47381420-BC515847-B4D8-4889-978A-A0E15DC49FEEQ47445269-A1BD826B-21F8-4F90-B651-7F48E514721DQ47873103-1029E823-63C3-4C6B-916A-8F5F32783EEFQ49484413-9AE42D09-ACC4-4B75-950B-D294948DFEA8Q52657068-C4BC7E83-581F-47DF-A6B3-045849545E10Q54096027-5A30AF52-93EE-4735-BFDC-B3527FD4A50BQ54978294-55E9843D-D9DC-4299-B1A4-64B644B6A627Q54986959-2F111C47-F886-4150-B007-4309FE84C8C0Q55261545-88CA35D1-4D0B-4349-B706-9806C3369F6AQ55283746-6562DCDE-6CC7-4F1A-8094-983CF344F71C
P2860
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@en
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@nl
type
label
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@en
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@nl
prefLabel
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@en
Revisiting Type 2-high and Typ ...... and therapeutic implications.
@nl
P2093
P2860
P50
P356
P1476
Revisiting Type 2-high and Typ ...... e and therapeutic implications
@en
P2093
P2860
P304
P356
10.1111/CEA.12880
P577
2017-02-01T00:00:00Z